(Q41564757)

3 October 2017

Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9. (English)

1 reference

3 October 2017

Milis L

1

1 reference

3 October 2017

Morris CA

2

1 reference

3 October 2017

Sheehan MC

3

1 reference

3 October 2017

Charlesworth JA

4

1 reference

3 October 2017

Pussell BA

5

1 reference

3 October 2017

1 April 1993

1 reference

Clinical and Experimental Immunology

3 October 2017

1 reference

3 October 2017

92

1 reference

3 October 2017

114-119

1 reference

3 October 2017

1

1 reference

The SC5b-7 complex: formation, isolation, properties, and subunit composition

3 October 2017

1 reference

12 December 2020

Identification of the collagen-binding domain of vitronectin using monoclonal antibodies

1 reference

12 December 2020

Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin

1 reference

12 December 2020

Activation of vitronectin (serum spreading factor) binding of heparin by denaturing agents

1 reference

12 December 2020

Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion.

1 reference

12 December 2020

Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor

1 reference

12 December 2020

Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans

1 reference

12 December 2020

The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities

1 reference

12 December 2020

Anti-fibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region

1 reference

12 December 2020

Novel purification of vitronectin from human plasma by heparin affinity chromatography.

1 reference

12 December 2020

Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes

1 reference

12 December 2020

The pathobiology of the terminal complement complexes.

1 reference

12 December 2020

Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin

1 reference

12 December 2020

Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin

1 reference

12 December 2020

SP-40,40 is an inhibitor of C5b-6-initiated haemolysis

1 reference

12 December 2020

Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin

1 reference

12 December 2020

Structure and Biological Role of Vitronectin

1 reference

12 December 2020

Activation of the collagen-binding of endogenous serum vitronectin by heating, urea and glycosaminoglycans

1 reference

12 December 2020

Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein

1 reference

12 December 2020

10.1111/J.1365-2249.1993.TB05956.X

Identifiers

DOI

1 reference

3 October 2017

0 references

1 reference